Technologies

Parkinson’s is caused by the aggregation and accumulation of α-synuclein protein in the brain, which gets deposited many years before symptoms appear. These misfolded proteins build up in the brain, causing it to stop functioning properly. Ultra-low levels of these seeds circulate in the affected person’s blood. The image illustrates a schematic representation of amplification of amyloid seeds through series of sonication-incubation. Prof. Maji and his team have developed a method to amplify low concentrations of circulating α-Syn using amyloid amplification similar to Polymerase Chain Reaction (PCR). Clinical trials (~300 samples) achieved more than 90% accuracy in detecting Parkinson’s disease.

NeuroScan360 is an AI-powered platform designed for early detection and monitoring of neurodegenerative conditions including Parkinson’s, Alzheimer’s disease, Dementia, and Ataxia. By leveraging real-time data, analytics, and machine learning, it provides objective and reproducible results.

Key Features of NeuroScan360

• Multiparametric screening
• Integrated wearable and portable system
• User interactive platform
• Facilitating early detection
• Accurate disease classification

The Empathy Suit is intended for researchers, policymakers, city planners, healthcare professionals, and volunteers who wish to experience the mobility issues faced by elderly citizens. The Voluntary Aging Device (VAD) simulates physical limitations and discomforts associated with aging, fostering empathy and understanding.